Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease.
J Crohns Colitis
; 2023 Nov 02.
Article
in En
| MEDLINE
| ID: mdl-37934041
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Crohns Colitis
Journal subject:
GASTROENTEROLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido